Loading stock data…
BBLG
$1.31+0.02 (+1.81%)
Market ClosedLast close May 1
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bone Biologics Corporation in the Healthcare sector is trading at $1.31. The stock is currently near its 52-week low of $1.05, remaining 28.6% below its 200-day moving average. Technical signals show neutral RSI of 61 and bearish MACD signal, explaining why BBLG maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 61) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.31
Potential Upside
5%
Whystock Fair Value$1.38
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus1 analysts
Mean target$22.20+1590.3%
Range$22.20 – $22.20
Fundamentals
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.44M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.37
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-57.81%
Volume
Today's trading volume
8,555
Recent News
BC-Most Active Stocks
td class="col-issue">Next Technology Holding Inc.
Traders Digest Fed's Preferred Inflation Gauge as US Equity Futures Gain Pre-Bell
US equity futures were up ahead of Friday's opening bell as traders digested the Federal Reserve's p